ReviewCureus2026
Depression as a Risk Factor for Dementia and Cognitive Decline in Type 2 Diabetes Mellitus: A Systematic Review of Longitudinal Studies.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is highly prevalent among individuals with type 2 diabetes mellitus (T2DM) and has been increasingly recognized as a potential contributor to adverse cognitive outcomes. While both depression and diabetes independently increase the risk of cognitive decline and dementia, their combined impact on cognitive health remains an area of growing clinical interest. This systematic review aimed to evaluate the association between depression and cognitive outcomes in individuals with T2DM. A systematic literature search was conducted in PubMed to identify relevant studies published between January 1, 2015, and December 31, 2025. The final search was performed on February 15, 2026. The search strategy combined Medical Subject Headings (MeSH) and free-text terms related to type 2 diabetes, depression, dementia, mild cognitive impairment, and cognitive decline. Studies were eligible if depression was assessed at baseline and cognitive outcomes were evaluated longitudinally through incident dementia diagnosis or repeated cognitive testing, enabling assessment of cognitive decline trajectories. Six studies met the predefined eligibility criteria and were included in the qualitative synthesis. Across the included studies, depression was consistently associated with adverse cognitive outcomes in individuals with T2DM. Longitudinal cohort studies demonstrated increased risk of incident dementia, with reported hazard ratios ranging approximately from 2.17 to 2.59. Other studies reported accelerated cognitive decline or increased risk of mild cognitive impairment among individuals with coexisting depression and diabetes. Depression appears to be an important and potentially modifiable risk factor for cognitive decline and dementia among individuals with type 2 diabetes. Early identification and effective management of depressive symptoms in patients with diabetes may help reduce the risk of adverse cognitive outcomes and support preservation of cognitive health in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.